Clinical studies are research projects where scientists test new medical treatments, drugs, devices, or behavioral approaches on human volunteers. These studies range from testing a new diabetes medication to studying how different therapy methods affect anxiety, or evaluating a medical device that might help people with heart conditions. Researchers need real people to participate because lab testing alone cannot tell us whether something will work safely and effectively in humans.
Learn About Paying Your FGUA Bill Online →
Paid clinical studies offer compensation to participants for their time, travel, and inconvenience—not as payment for the medical risk itself, but as recognition that participation requires a significant commitment. The payment amounts vary dramatically depending on what the study involves. A one-visit study where you simply answer survey questions about your health history might pay $25 to $100. A multi-week study requiring overnight stays at a research facility could pay $1,000 to $10,000 or more. Phase I drug studies (the earliest testing stage) often pay more than Phase II or Phase III studies because they involve testing new substances in humans for the first time, which carries unknown risks.
Understanding the structure of clinical research helps explain why some studies pay more than others. Early-stage studies testing brand-new treatments typically involve smaller groups and longer observation periods, which justifies higher compensation. Later-stage studies confirming that a treatment works often involve larger groups but shorter individual participation periods, so they may pay less per person.
Practical takeaway: Payment reflects the burden placed on you—the more intensive the study, the higher the compensation. Before considering any study, understand what "burden" means: how many visits, how long each visit lasts, what procedures you'll undergo, and whether you'll need time off work.
Finding legitimate paid clinical studies requires knowing where to look. The primary resource is ClinicalTrials.gov, a government database maintained by the National Institutes of Health that lists over 400,000 studies worldwide. You can search by condition, location, study phase, and enrollment status. This free database doesn't handle recruitment itself—it simply lists studies and provides contact information for the research sites running them. You then contact the site directly to learn more.
Free Guide to Pay by Plate Illinois Billing →
Universities and medical centers in your area often run their own clinical research departments. Major research hospitals typically have websites listing active studies, sometimes organized by medical specialty. Calling the research department directly at a local hospital is a straightforward way to learn what studies are recruiting. Some studies recruit through specific patient organizations—for example, a study on a rare disease might be listed on that disease's foundation website.
Private research companies and Contract Research Organizations (CROs) also conduct studies. These companies are hired by pharmaceutical companies or medical device makers to run clinical trials. Some maintain websites listing open studies in your region. Research clinics in urban areas sometimes advertise studies through social media or local ads, though you should verify any study through ClinicalTrials.gov before contacting them.
Beyond these official channels, be cautious about how you search. Studies advertised on random websites without verification through ClinicalTrials.gov may be legitimate, but you cannot confirm this as easily. Scams do exist in this space—fake studies that collect personal information or claim to need upfront payments. Legitimate studies never ask for money upfront, and they never contact you unsolicited asking for payment information.
Practical takeaway: Start with ClinicalTrials.gov for verified information, or contact research departments at nearby medical institutions. Cross-reference any study you find through other means by searching for it on ClinicalTrials.gov to confirm it's real before responding to recruitment ads.
Clinical drug studies follow four phases, each with different purposes, participant numbers, and compensation levels. Knowing which phase you're considering tells you what to expect in terms of time commitment, risk level, and payment.
Free Guide to Mold Removal Methods for Walls →
Phase I studies are the first time a new drug or treatment is tested in humans after laboratory work. These studies typically involve 20 to 100 healthy volunteers (not people with the disease being treated) and focus on safety and dosage. Phase I studies last weeks to months and often require multiple visits or overnight stays. Because this is the first time the substance is being tested in humans, the risks are unknown and potentially significant, which is why Phase I studies often offer the highest compensation—sometimes $500 to $15,000 depending on the commitment. These studies are intensive; you may need to live at a research facility for several days and undergo frequent blood draws, EKGs, or imaging scans.
Phase II studies test whether the treatment actually works for the intended condition, not just whether it's safe. These involve 100 to 500 people who actually have the disease or condition being studied. Phase II lasts several months and requires more frequent appointments than Phase I but usually doesn't involve overnight stays. Compensation ranges from $200 to $5,000, depending on how often you visit and what procedures are involved. The risks are still significant because you're testing a relatively new treatment, but it's no longer completely untested in humans.
Phase III studies compare the new treatment to existing treatments (or placebos) to see which works better. These involve 1,000 to 5,000 participants and last one to four years. Most Phase III participants are treated as outpatients—you visit a clinic but don't stay overnight. Compensation is typically $100 to $2,000 total, since visits may be spread over years and the treatment has already proven reasonably safe in Phase II. Phase III studies have lower risk than earlier phases because the treatment has been tested more extensively.
Phase IV studies monitor approved treatments already on the market to track long-term effects and side effects. These are ongoing research on medications people already take anyway, so participation might mean extra clinic visits or surveys to report your health. Compensation is usually $50 to $500 depending on frequency of contact.
Practical takeaway: Understand that earlier phases mean higher payment but also higher unknown risk. Phase I pays best but requires the most commitment and carries the most uncertainty. Later phases are lower risk and more predictable but pay less.
Before participating in any clinical study, you need information that goes beyond just payment amount. The research site should provide you with a document called an "informed consent form" that explains what the study involves, what risks exist, what happens if something goes wrong, and your rights as a participant. Reading this document thoroughly is essential. It's often long and technical, but it contains critical information.
How to Delete Your Fitbit Account Guide →
Key information to understand before joining any study includes: the study's purpose and phase, how many visits or days of participation are required, what happens at each visit, whether there are overnight stays, what procedures you'll undergo (blood draws, imaging, surgery, medication, etc.), what the possible side effects are (both common and serious), how long results will be tracked after the study ends, whether you can withdraw at any time without penalty, how your data will be protected, who is funding the study, and what medical support is available if you experience problems.
You should also understand the specific eligibility criteria the study uses. These aren't about judgment—they're about scientific accuracy. A study testing a drug for high blood pressure might only enroll people with untreated high blood pressure, or might exclude people taking certain other medications that could interfere with results. Understanding why you do or don't meet criteria helps you assess whether the study is actually appropriate for you.
Ask the research coordinator these practical questions: What happens if I get sick during the study? Is there a doctor on-site if something goes wrong? If serious problems occur, will the study cover medical costs? How is my personal information kept confidential? Can I talk to people who've already completed this study? What happens to my data after the study ends? Will I find out the results? Can I stop participating whenever I want, and what happens to my compensation if I do?
Red flags that suggest caution include: the study offering unusually high payment for minimal time commitment (may indicate underestimated risks), reluctance to answer your questions clearly, pressure to decide quickly, requests for upfront payments, studies not listed on ClinicalTrials.gov, or guarantees that a treatment will work.
Practical takeaway: Read the entire informed consent form, ask questions until you understand exactly what's involved, and verify the study on ClinicalTrials.gov. Take time to decide—legitimate studies won't pressure you to commit immediately.
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.